Works matching DE "BLOOD coagulation factor VII"

Results: 24

Recombinant factor VIIa as a rescue therapy in severe haemoptysis in a patient with a Fontan circulation.

Published in:

2018

By:

Mason, Thomas W.;
Retter, Andrew;
Morgan, Gareth J.

Publication type:

journal article

Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: A Sonoclot in vitro study.

Published in:

Scandinavian Journal of Clinical & Laboratory Investigation, 2014, v. 74, n. 7, p. 591, doi. 10.3109/00365513.2014.921930

By:

Sølbeck, Sacha;
Nilsson, Caroline U.;
Engström, Martin;
Ostrowski, Sisse R.;
Johansson, Pär I.

Publication type:

Article

Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.

Published in:

Pharmacotherapy, 2016, v. 36, n. 10, p. 1047, doi. 10.1002/phar.1827

By:

Kwon, Jennifer O.;
MacLaren, Robert

Publication type:

Article

Use of Activated Factor VII in Patients with Diffuse Alveolar Hemorrhage: A 10 Years Institutional Experience.

Published in:

Lung (0341-2040), 2015, v. 193, n. 3, p. 375, doi. 10.1007/s00408-015-9720-z

By:

Pathak, Vikas;
Kuhn, Judy;
Gabriel, Don;
Barrow, Jennifer;
Jennette, J.;
Henke, David

Publication type:

Article

Tissue Factor--Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.

Published in:

Biomarkers in Cancer, 2015, n. 7, p. 1, doi. 10.4137/BIC.s29318

By:

Shiro Koizume;
Yohei Miyagi

Publication type:

Article

Alternatives to allogeneic platelet transfusion.

Published in:

British Journal of Haematology, 2016, v. 175, n. 3, p. 381, doi. 10.1111/bjh.14338

By:

Desborough, Michael J. R.;
Smethurst, Peter A.;
Estcourt, Lise J.;
Stanworth, Simon J.

Publication type:

Article

Successful treatment of intracranial hemorrhage with recombinant activated factor VII in a patient with newly diagnosed acute myeloid leukemia: a case report and review of the literature.

Published in:

2015

By:

Pemmaraju, Naveen;
Sasaki, Koji;
Daver, Naval;
Borthakur, Gautam;
Johnson, Daniel;
Afshar-Kharghan, Vahid;
Merry Chen;
Ahmed, Sairah;
Colen, Rivka R.;
Michael Kwon;
Yang Huh

Publication type:

Case Study

Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies.

Published in:

European Journal of Haematology, 2015, v. 94, p. 30, doi. 10.1111/ejh.12499

By:

Baghaipour, Mohammad Reza;
Steen Carlsson, Katarina

Publication type:

Article

P341Activation of beta1-integrins and caveolin-1 by TF/FVIIa promotes cell survival.

Published in:

2018

By:

Aberg, M;
Eden, D;
Siegbahn, A

Publication type:

Abstract

Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1 A: a single tertiary academic centre experience.

Published in:

Vox Sanguinis, 2014, v. 106, n. 1, p. 75, doi. 10.1111/vox.12067

By:

Pham, H. P.;
Hsu, S. X.;
Parker‐Jones, S.;
Samstein, B.;
Diuguid, D.;
Schwartz, J.

Publication type:

Article

Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion.

Published in:

Transfusion, 2012, v. 52, n. 8, p. 1696, doi. 10.1111/j.1537-2995.2011.03505.x

By:

Ho, Kwok M.;
Litton, Edward

Publication type:

Article

The Danger of Using a Sledgehammer to Crack a Nut: ROTEM-Guided Administration of Recombinant Activated Factor VII in a Patient With Refractory Bleeding Post-Ventricular Assist Device Implantation.

Published in:

Artificial Organs, 2015, v. 39, n. 3, p. 248, doi. 10.1111/aor.12355

By:

Tarzia, Vincenzo;
Buratto, Edward;
Bortolussi, Giacomo;
Paolini, Carla;
Bejko, Jonida;
Bottio, Tomaso;
Gerosa, Gino

Publication type:

Article

The first reported case of acquired haemophilia A in which bleeding episodes were successfully treated via administration of a single‐dose mixture of activated factor VIIa/X.

Published in:

Haemophilia, 2019, v. 25, n. 5, p. e350, doi. 10.1111/hae.13843

By:

Yamada, Shinya;
Arahata, Masahisa;
Morishita, Eriko;
Ichinose, Akitada;
Asakura, Hidesaku

Publication type:

Article

Kinetic analysis and binding studies of a new recombinant human factor VIIa for treatment of haemophilia.

Published in:

Haemophilia, 2017, v. 23, n. 2, p. 300, doi. 10.1111/hae.13110

By:

Grandoni, J.;
Perret, G.;
Forier, C.

Publication type:

Article

Inhibitor development after liver transplantation in congenital factor VII deficiency.

Published in:

Haemophilia, 2016, v. 22, n. 5, p. e417, doi. 10.1111/hae.13047

By:

See, W. ‐ S. Q.;
Chang, K. ‐ O;
Cheuk, D. K. ‐ L.;
Leung, Y. ‐ Y. R.;
Chan, G. C. ‐ F.;
Chan, S. ‐ C.;
Ha, S. ‐ Y.

Publication type:

Article

The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort.

Published in:

Haemophilia, 2015, v. 21, n. 5, p. 670, doi. 10.1111/hae.12645

By:

Rabelo, F.Y.;
Jardim, L. L.;
Landau, M. B.;
Gadelha, T.;
Corrêa, M. F. B.;
Pereira, I.F.M.;
Rezende, S. M.

Publication type:

Article

Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Published in:

Haemophilia, 2015, v. 21, n. 5, p. 636, doi. 10.1111/hae.12664

By:

Rydz, N.;
Grabell, J.;
Lillicrap, D.;
James, P. D.

Publication type:

Article

Switching to low dose of plasma-derived factor VIII/ vWF concentrates with Confact<sup>®</sup>-F as salvage immune tolerance induction in haemophilia A patients with inhibitors: five case reports from Japan.

Published in:

Haemophilia, 2015, v. 21, n. 5, p. e425, doi. 10.1111/hae.12728

By:

Nagao, A.;
Oka, T.;
Hanabusa, H.

Publication type:

Article

Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.

Published in:

Haemophilia, 2015, v. 21, n. 1, p. e116, doi. 10.1111/hae.12589

By:

Tuffigo, M.;
Lazaro, E.;
James, C.;
Subtil, C.;
Viallard, J.‐F.;
Fiore, M.

Publication type:

Article

Inhibitors to factor VII in congenital factor VII deficiency.

Published in:

Haemophilia, 2014, v. 20, n. 2, p. e188, doi. 10.1111/hae.12376

By:

Batorova, A.;
Mariani, G.;
Kavakli, K.;
Saez, A. R.;
Caliskan, Ü.;
Karimi, M.;
Pinotti, M.;
Napolitano, M.;
Dolce, A.;
Sørensen, B.;
Ingerslev, J.

Publication type:

Article

On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.

Published in:

Haemophilia, 2012, v. 18, n. 2, p. 255, doi. 10.1111/j.1365-2516.2011.02612.x

By:

SØRENSEN, B.;
DARGAUD, Y.;
KENET, G.;
LUSHER, J.;
MUMFORD, A.;
PIPE, S.;
TIEDE, A.

Publication type:

Article

Successful Control of Massive Bleeding in a Child with Burkitt’s Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven™).

Published in:

2016

By:

Goudarzi Pour, Kourosh;
Malek, Fatemeh;
Eshghi, Peyman

Publication type:

Case Study

Mechanisms of coexistence of factor VII hyperactivity with dyslipidaemia, diabetes mellitus, obesity and its role in the development of myocardial infarction: A review.

Published in:

African Journal for Physical, Health Education, Recreation & Dance, 2015, v. 21, n. 2:2, p. 519

By:

MORABA, M. M.;
MABUSELA, M. S.;
MASHINYA, F.;
DIKOTOPE, S. A.;
CHOMA, S. S. R.

Publication type:

Article

Association of elevated Factor VII activity with hyperglycaemia, dyslipidaemia and obesity in a rural black community in Limpopo Province, South Africa.

Published in:

African Journal for Physical, Health Education, Recreation & Dance, 2013, v. 19, n. 3, p. 555

By:

SENGWAYO, D. G.;
MORABA, M. M.;
MOTAUNG, S. C. K. M.

Publication type:

Article